• The central feature of medical ethics is the primacy of the patient’s interests.
• The ethical obligations of a for-profit corporation include maximizing profit and growth.
• The rise of entrepreneurialism and the growing corporatization of medicine also challenge the traditions of virtue-based medical care. When these processes are allowed to dominate medicine, health care becomes a commodity.
• The different obligations of business and medical ethics call the appropriateness of applying industrial models to provision of health care into question. It is no less than each of our professional duties to address these tensions where they exist.

• Recently developed dual-energy chest radiographs can detect calcium in lesions or remove overlapping bone to confirm the presence of a lesion
• Automatic tube current and tube potential modulation reduces computed tomography radiation risk by optimizing the radiation dose to the patient size and scan region
• Positron emission tomography has limited applicability in low-grade adenocarcinoma and carcinoid tumors owing to poor fluorodeoxyglucose uptake in these clinical concerns

• The central feature of medical ethics is the primacy of the patient’s interests.
• The ethical obligations of a for-profit corporation include maximizing profit and growth.
• The rise of entrepreneurialism and the growing corporatization of medicine also challenge the traditions of virtue-based medical care. When these processes are allowed to dominate medicine, health care becomes a commodity.
• The different obligations of business and medical ethics call the appropriateness of applying industrial models to provision of health care into question. It is no less than each of our professional duties to address these tensions where they exist.

• Minimally invasive platforms facilitate removal of rectal tumors that are beyond the reach of conventional transanal excision techniques.
• The use of neoadjuvant chemoradiotherapy may make local excision a viable option for T2 rectal tumors.
• Outcomes for immediate salvage surgery are generally better than for delayed salvage surgery.

• Emerging role of beta agonist therapy for treatment of OAB
• The pharmacologic use of onabotulinumtoxinA (Botox®) upgraded to strongest rating of “standard" (strength of evidence grade B) by the amended 2014 AUA/SUFU guidelines.
• Studies reporting trigonal injections of Botox may be associated with superior continence rates

• Evidence-based guidelines are now available to help assess risk and selection of pharmacologic options for pain control. 
• Mechanism-based selection of analgesic medications is likely to maximize analgesic coverage by improving efficacy and reducing adverse effects and cost of treatment.
• The need to identify alternative viable treatment options is evident with an increase in system restrictions.

• 2019 ASCRS Practice Guidelines Update. See Table 9 for further details.
• Recent advances in multimodality treatment of appendiceal neoplasm with peritoneal involvement including surgery and intraperitoneal chemotherapy.
• Current trends in intraperitoneal chemotherapy: hyperthermic intraperitoneal chemotherapy (HIPEC) versus early postoperative intraperitoneal chemotherapy (EPIC).
• Recent advances in understanding low-grade appendiceal neoplasm and the focus of current and future clinical trials.

Enhanced recovery after surgery (ERAS) pathways have been advanced for the purposes of cost containment, standardization of care, and standardization of surgical outcomes. Adoption of an ERAS pathway has been associated with a shortened length of hospital stay and improved outcomes in colorectal surgery in randomized prospective trials, which has led to the implementation of the ERAS approach in other procedures. Each pathway is specific to a given procedure, and no universal postoperative pathway has been proposed or investigated.